• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种通过纳米气泡和超声肢体灌注用于骨骼肌给药的基因和核酸递送系统的开发。

Development of a Gene and Nucleic Acid Delivery System for Skeletal Muscle Administration via Limb Perfusion Using Nanobubbles and Ultrasound.

作者信息

Sekine Shohko, Mayama Sayaka, Nishijima Nobuaki, Kojima Takuo, Endo-Takahashi Yoko, Ishii Yuko, Shiono Hitomi, Akiyama Saki, Sakurai Akane, Sashida Sanae, Hamano Nobuhito, Tada Rui, Suzuki Ryo, Maruyama Kazuo, Negishi Yoichi

机构信息

Department of Drug Delivery and Molecular Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.

Laboratory of Drug and Gene Delivery Research, Faculty of Pharma-Sciences, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.

出版信息

Pharmaceutics. 2023 Jun 6;15(6):1665. doi: 10.3390/pharmaceutics15061665.

DOI:10.3390/pharmaceutics15061665
PMID:37376113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10302710/
Abstract

Strategies for gene and nucleic acid delivery to skeletal muscles have been extensively explored to treat Duchenne muscular dystrophy (DMD) and other neuromuscular diseases. Of these, effective intravascular delivery of naked plasmid DNA (pDNA) and nucleic acids into muscles is an attractive approach, given the high capillary density in close contact with myofibers. We developed lipid-based nanobubbles (NBs) using polyethylene-glycol-modified liposomes and an echo-contrast gas and found that these NBs could improve tissue permeability by ultrasound (US)-induced cavitation. Herein, we delivered naked pDNA or antisense phosphorodiamidate morpholino oligomers (PMOs) into the regional hindlimb muscle via limb perfusion using NBs and US exposure. pDNA encoding the luciferase gene was injected with NBs via limb perfusion into normal mice with application of US. High luciferase activity was achieved in a wide area of the limb muscle. DMD model mice were administered PMOs, designed to skip the mutated exon 23 of the dystrophin gene, with NBs via intravenous limb perfusion, followed by US exposure. The number of dystrophin-positive fibers increased in the muscles of mdx mice. Combining NBs and US exposure, which can be widely delivered to the hind limb muscles via the limb vein, could be an effective therapeutic approach for DMD and other neuromuscular disorders.

摘要

为治疗杜氏肌营养不良症(DMD)和其他神经肌肉疾病,人们已广泛探索了将基因和核酸递送至骨骼肌的策略。其中,鉴于与肌纤维紧密接触的高毛细血管密度,将裸露的质粒DNA(pDNA)和核酸有效血管内递送至肌肉是一种有吸引力的方法。我们使用聚乙二醇修饰的脂质体和一种超声造影气体开发了基于脂质的纳米气泡(NBs),并发现这些NBs可通过超声(US)诱导的空化作用提高组织通透性。在此,我们通过使用NBs和US照射的肢体灌注,将裸露的pDNA或反义磷酰胺吗啉代寡聚物(PMOs)递送至后肢局部肌肉。编码荧光素酶基因的pDNA通过肢体灌注与NBs一起注射到正常小鼠体内,并施加US。在肢体肌肉的广泛区域实现了高荧光素酶活性。DMD模型小鼠通过静脉肢体灌注接受与NBs一起给药的PMOs,这些PMOs旨在跳过肌营养不良蛋白基因的突变外显子23,随后进行US照射。mdx小鼠肌肉中抗肌萎缩蛋白阳性纤维的数量增加。将NBs和US照射相结合,可通过肢体静脉广泛递送至后肢肌肉,可能是治疗DMD和其他神经肌肉疾病的有效治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/c7d3da01d8f5/pharmaceutics-15-01665-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/fdb98d31c682/pharmaceutics-15-01665-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/7db8145c3190/pharmaceutics-15-01665-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/fbb60a121ee6/pharmaceutics-15-01665-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/fe68069834b9/pharmaceutics-15-01665-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/83f47047a280/pharmaceutics-15-01665-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/62a34a6f54af/pharmaceutics-15-01665-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/7d650a34d140/pharmaceutics-15-01665-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/c7d3da01d8f5/pharmaceutics-15-01665-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/fdb98d31c682/pharmaceutics-15-01665-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/7db8145c3190/pharmaceutics-15-01665-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/fbb60a121ee6/pharmaceutics-15-01665-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/fe68069834b9/pharmaceutics-15-01665-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/83f47047a280/pharmaceutics-15-01665-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/62a34a6f54af/pharmaceutics-15-01665-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/7d650a34d140/pharmaceutics-15-01665-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce60/10302710/c7d3da01d8f5/pharmaceutics-15-01665-g008.jpg

相似文献

1
Development of a Gene and Nucleic Acid Delivery System for Skeletal Muscle Administration via Limb Perfusion Using Nanobubbles and Ultrasound.一种通过纳米气泡和超声肢体灌注用于骨骼肌给药的基因和核酸递送系统的开发。
Pharmaceutics. 2023 Jun 6;15(6):1665. doi: 10.3390/pharmaceutics15061665.
2
Bubble liposomes and ultrasound exposure improve localized morpholino oligomer delivery into the skeletal muscles of dystrophic mdx mice.气泡脂质体和超声照射可改善吗啉代寡聚物在营养不良性mdx小鼠骨骼肌中的局部递送。
Mol Pharm. 2014 Mar 3;11(3):1053-61. doi: 10.1021/mp4004755. Epub 2014 Jan 27.
3
PMO Delivery System Using Bubble Liposomes and Ultrasound Exposure for Duchenne Muscular Dystrophy Treatment.使用气泡脂质体和超声照射的PMO递送系统用于杜氏肌营养不良症的治疗。
Methods Mol Biol. 2018;1687:185-192. doi: 10.1007/978-1-4939-7374-3_13.
4
In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.反义磷酰二胺吗啉代寡聚物(PMO)在营养不良犬和7号外显子缺失的杜氏肌营养不良症(DMD)患者中诱导的体外多外显子跳跃
Methods Mol Biol. 2018;1828:151-163. doi: 10.1007/978-1-4939-8651-4_9.
5
The mechanism of naked DNA uptake and expression.裸露DNA摄取与表达的机制。
Adv Genet. 2005;54:3-20. doi: 10.1016/S0065-2660(05)54001-X.
6
Functional efficacy of dystrophin expression from plasmids delivered to mdx mice by hydrodynamic limb vein injection.经 hydrodynamic limb vein injection 途径给予 mdx 小鼠的质粒表达的 dystrophin 的功能疗效。
Hum Gene Ther. 2010 Feb;21(2):221-37. doi: 10.1089/hum.2009.133.
7
Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA.通过血管内注射含全长抗肌萎缩蛋白cDNA的裸DNA来恢复mdx小鼠的抗肌萎缩蛋白表达。
Gene Ther. 2004 Jun;11(11):901-8. doi: 10.1038/sj.gt.3302239.
8
Dosing regimen has a significant impact on the efficiency of morpholino oligomer-induced exon skipping in mdx mice.给药方案对吗啉代寡聚物诱导mdx小鼠外显子跳跃的效率有显著影响。
Hum Gene Ther. 2009 Sep;20(9):955-65. doi: 10.1089/hum.2008.157.
9
In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.肽基磷酰二胺吗啉代寡聚物介导的多外显子跳跃在营养不良犬心脏和骨骼肌中的体内评估
Methods Mol Biol. 2018;1828:365-379. doi: 10.1007/978-1-4939-8651-4_23.
10
Scavenger Receptor Class A1 Mediates Uptake of Morpholino Antisense Oligonucleotide into Dystrophic Skeletal Muscle.清道夫受体A1类介导吗啉代反义寡核苷酸进入营养不良性骨骼肌。
Mol Ther Nucleic Acids. 2019 Mar 1;14:520-535. doi: 10.1016/j.omtn.2019.01.008. Epub 2019 Jan 25.

引用本文的文献

1
Engineering Targeted Gene Delivery Systems for Primary Hereditary Skeletal Myopathies: Current Strategies and Future Perspectives.用于原发性遗传性骨骼肌病的靶向基因递送系统工程:当前策略与未来展望
Biomedicines. 2025 Aug 16;13(8):1994. doi: 10.3390/biomedicines13081994.
2
Phosphorodiamidate Morpholino Oligomers-Loaded Nanobubbles for Ultrasound-Mediated Delivery to the Myocardium in Muscular Dystrophy.用于超声介导递送至肌营养不良症心肌的磷酰二胺吗啉代寡聚物负载纳米气泡
ACS Omega. 2025 Feb 27;10(9):9639-9648. doi: 10.1021/acsomega.4c10896. eCollection 2025 Mar 11.
3
Liposome-Enabled Nanomaterials for Muscle Regeneration.

本文引用的文献

1
Prolonged control of insulin-dependent diabetes via intramuscular expression of plasmid-encoded single-strand insulin analogue.通过质粒编码的单链胰岛素类似物的肌肉内表达实现胰岛素依赖型糖尿病的长期控制。
Genes Dis. 2022 May 24;10(3):1101-1113. doi: 10.1016/j.gendis.2022.05.009. eCollection 2023 May.
2
Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations.用于肿瘤微环境治疗性编程的重组病毒载体:优势与局限
Biomedicines. 2022 Aug 31;10(9):2142. doi: 10.3390/biomedicines10092142.
3
CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy.
用于肌肉再生的脂质体纳米材料
Small Methods. 2025 Feb 18:e2402154. doi: 10.1002/smtd.202402154.
4
Delivery of genetic medicines for muscular dystrophies.用于治疗肌肉萎缩症的基因药物递送
Cell Rep Med. 2025 Jan 21;6(1):101885. doi: 10.1016/j.xcrm.2024.101885. Epub 2025 Jan 6.
CRISPR-Cas9 基因治疗杜氏肌营养不良症。
Neurotherapeutics. 2022 Apr;19(3):931-941. doi: 10.1007/s13311-022-01197-9. Epub 2022 Feb 14.
4
Ultrasonic particles: An approach for targeted gene delivery.超声粒子:一种靶向基因传递的方法。
Adv Drug Deliv Rev. 2021 Dec;179:113998. doi: 10.1016/j.addr.2021.113998. Epub 2021 Oct 15.
5
Ternary Complexes of pDNA, Neuron-Binding Peptide, and PEGylated Polyethyleneimine for Brain Delivery with Nano-Bubbles and Ultrasound.用于通过纳米气泡和超声实现脑递送的质粒DNA、神经元结合肽和聚乙二醇化聚乙烯亚胺三元复合物
Pharmaceutics. 2021 Jul 1;13(7):1003. doi: 10.3390/pharmaceutics13071003.
6
Microbubbles and Nanobubbles with Ultrasound for Systemic Gene Delivery.用于全身基因递送的微泡和纳米泡与超声技术
Pharmaceutics. 2020 Oct 14;12(10):964. doi: 10.3390/pharmaceutics12100964.
7
Advances in oligonucleotide drug delivery.寡核苷酸药物递送的进展。
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11.
8
Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system.通过自互补 AAV 递送系统增强 CRISPR-Cas9 对杜氏肌营养不良症小鼠的校正。
Sci Adv. 2020 Feb 19;6(8):eaay6812. doi: 10.1126/sciadv.aay6812. eCollection 2020 Feb.
9
Gene transfer to skeletal muscle using hydrodynamic limb vein injection: current applications, hurdles and possible optimizations.通过水动力肢体静脉注射将基因转移至骨骼肌:当前应用、障碍及可能的优化措施
J Gene Med. 2020 Feb;22(2):e3150. doi: 10.1002/jgm.3150. Epub 2020 Jan 20.
10
CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells.CRISPR-Cas9 纠正了小鼠和人细胞中杜氏肌营养不良症外显子 44 缺失突变。
Sci Adv. 2019 Mar 6;5(3):eaav4324. doi: 10.1126/sciadv.aav4324. eCollection 2019 Mar.